Polycystic kidney disease: open trials in Spain

• NCT04782258

  A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

  Trial Treatment · Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc.

  Hospital Universitari Vall d'Hebron, Barcelona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat

  Registry updated 2026-10-23

• NCT06902558

  ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  Trial Treatment · Phase 2 · Calico Life Sciences LLC

  Fundació Puigvert, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia

  Registry updated 2026-10-06

• NCT05373264

  HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

  Trial Treatment · Phase 3 · University Medical Center Groningen

  Hospital General La Mancha Centro, Alcázar de San Juan · Fundació Puigvert, Barcelona · Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid

  Registry updated 2026-08-25

• NCT07280585

  STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

  Trial Treatment · Phase 3 · University of Cologne

  Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Fundació Puigvert, Barcelona

  Registry updated 2026-07-28

All Polycystic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error